Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
about
Damage control: cellular mechanisms of plasma membrane repairPrion protein accumulation in lipid rafts of mouse aging brainAbove the fray: Surface remodeling by secreted lysosomal enzymes leads to endocytosis-mediated plasma membrane repairInsights into sphingolipid miscibility: separate observation of sphingomyelin and ceramide N-acyl chain melting.Developmentally regulated sphingolipid degradation in Leishmania majorExocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair.A high-throughput sphingomyelinase assay using natural substrate.CD39 and CD161 modulate Th17 responses in Crohn's disease.S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism.The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease.Requirement of translocated lysosomal V1 H(+)-ATPase for activation of membrane acid sphingomyelinase and raft clustering in coronary endothelial cells.Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses.Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy.Evidence for coordination of lysosomal (ASMase) and plasma membrane (NSMase2) forms of sphingomyelinase from mutant mice.Inhibition of Acid Sphingomyelinase Depletes Cellular Phosphatidylserine and Mislocalizes K-Ras from the Plasma Membrane.Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading.Levels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometryThe antiproliferative effect of C2-ceramide on lung cancer cells through apoptosis by inhibiting Akt and NFκB.Group XV phospholipase A₂, a lysosomal phospholipase A₂.Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.Do annexins participate in lipid messenger mediated intracellular signaling? A question revisited.Sphingolipids in the DNA damage response.Role of sphingomyelinases in neurological disorders.Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Amplification of a FRET Probe by Lipid-Water Partition for the Detection of Acid Sphingomyelinase in Live Cells.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.Identification and characterization of Laodelphax striatellus (Insecta: Hemiptera: Delphacidae) neutral sphingomyelinase.Perturbed cholesterol and vesicular trafficking associated with dengue blocking in Wolbachia-infected Aedes aegypti cells.Acid sphingomyelinase mediates human CD4+ T-cell signaling: potential roles in T-cell responses and diseases.Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium releaseDifferential association of the Na+/H+ Exchanger Regulatory Factor (NHERF) family of adaptor proteins with the raft- and the non-raft brush border membrane fractions of NHE3.ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium.Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.RETREG1 (FAM134B): a new player in human diseases: 15 years after the discovery in cancer.Inhibition of Acid Sphingomyelinase Disrupts LYNUS Signaling and Triggers Autophagy.
P2860
Q27022016-6BA2FB96-AF3B-4F11-BDDE-636F0B873C80Q27306972-63BFC384-690A-4220-8904-FCCE0EC7C1F8Q28084142-243C7650-2CB6-43C6-9497-BCEC65680CEEQ30445609-40F1258E-18B4-4217-81CE-ED054CF23990Q31047779-2BDEACA7-F8E2-40D1-BBD7-03183F3E1CF5Q33916052-C3CEC110-BAFE-4D8D-98CB-6FBC414D3F65Q34068492-06A1A373-84B2-4D06-BAD1-D7B80C3492A6Q34218735-14B2FA71-E219-484E-8576-7C3A59A5BAA0Q35006026-DDF6BB91-1F0C-41E6-90BC-5408C343ACE7Q35180049-174A1B8E-BBFB-4466-A285-0675C1EF6B32Q35324757-0FBE6C38-EBCC-4FC6-82E8-132F8F0BC416Q35668715-E1F19A95-CC8E-45A7-9E39-F04BEA0B4A61Q35891203-4E606F3A-7C9F-46FA-A8F8-C90C12F75395Q36293843-1A45E54B-3B34-4261-8B92-649E6FBE39D2Q36363960-C631036C-1C32-417A-A216-B65AC1303361Q36401748-80C22157-839C-4B34-96B2-0C21E9411518Q36480870-70BA81F1-C439-4083-ADAF-996B52F5CD77Q37127238-51E05A9D-A5DD-4DD4-B229-85F5DCE4ED6BQ37188851-17361916-C36B-46F2-A844-9124AD486E42Q37231652-C802B5FE-7504-48E6-8743-E0A6AA487821Q37484846-8F3C03C8-86C5-4222-8936-3AEF34B1FE93Q37809218-4503665D-698B-496A-B863-286FEF0D93F1Q37826106-879B648B-9958-44DA-9352-EA6E27CAE147Q37880161-55F18FAE-0278-4D42-BB59-1A3F7079FB54Q38018345-5586DAA7-5068-48F7-AFC7-B66D262708C1Q38272799-8A1E3F11-B27E-4634-9DBF-8CD4AA33037CQ38560939-2DDFA70B-BC3F-438A-A112-A9E6554033B5Q38607507-EB3409D4-698D-4189-8F22-117DA6AB8DE3Q38762263-A4A3406D-8E66-4E61-BCE3-6055C22ADEDFQ38831997-373E4596-E875-456A-815A-21B952044BC1Q38856868-0CA4DA3D-2E15-4A1F-846F-A402BB97D46AQ40039003-D59D8FDE-DBCB-48D1-A338-A99645C4B240Q41335687-F6F74056-3F37-49E3-B70F-B25B8CB0DB79Q41822869-935193D3-FFA2-4656-8933-C0EA39CA6B74Q41887224-7E812249-BD36-4191-BC12-C0F34A1EF7C1Q41921041-5DD91EE1-C06D-4EFA-BE90-1BFAF18FB0FAQ41933986-F6E5070D-9580-4F6C-8904-4A8C95F7DA91Q42005356-97B44839-04A2-4C69-897B-1A4B8DC40CB7Q47309478-406BD697-CFBF-44F3-A413-A66120232E8BQ49598164-AE477E3B-1ABB-42FE-845F-5302F0B581D3
P2860
Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@en
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@nl
type
label
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@en
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@nl
prefLabel
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@en
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@nl
P2860
P1433
P1476
Acid sphingomyelinase, cell me ...... ons from Niemann-Pick disease.
@en
P2093
Edward H Schuchman
P2860
P304
P356
10.1016/J.FEBSLET.2009.11.083
P407
P577
2009-11-26T00:00:00Z